BH

Bausch Health Companies Inc (BHC)

HealthcareDrug Manufacturers - Specialty & Generic
5.67USD
+0.27%
Magic Rank
#342
Earnings Yield
8.7%
Return on Capital
95.4%
Cap. Boursière
2.1B

Performance vs S&P 500 (5 ans)

BHC.US
S&P 500

À propos Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Analyse Magic Formula

Valeur d'Entreprise21.7B
Marché / Univers
us
USA

"Une entreprise avec un ROC élevé et un EY élevé a statistiquement plus de chances de surperformer le marché."

Indicateurs Clés

P/E RatioN/A
Rendement dividendeN/A
Dette / Fonds propres-35.38
Marge Brute25.8%